Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial

Background The recent data on the prevalence of Helicobacter pylori (H. pylori) infection in Russia are limited. The aim of the study was to compare Helicobacter pylori infection prevalence in ambulatory settings in Russia in 2017 and 2019 years. Materials and Methods Subjects visiting primary care...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Helicobacter (Cambridge, Mass.) Mass.), 2022-10, Vol.27 (5), p.e12924-n/a
Hauptverfasser: Bordin, Dmitry, Morozov, Sergey, Plavnik, Roman, Bakulina, Natalia, Voynovan, Irina, Skibo, Irina, Isakov, Vasily, Bakulin, Igor, Andreev, Dmitrii, Maev, Igor
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 5
container_start_page e12924
container_title Helicobacter (Cambridge, Mass.)
container_volume 27
creator Bordin, Dmitry
Morozov, Sergey
Plavnik, Roman
Bakulina, Natalia
Voynovan, Irina
Skibo, Irina
Isakov, Vasily
Bakulin, Igor
Andreev, Dmitrii
Maev, Igor
description Background The recent data on the prevalence of Helicobacter pylori (H. pylori) infection in Russia are limited. The aim of the study was to compare Helicobacter pylori infection prevalence in ambulatory settings in Russia in 2017 and 2019 years. Materials and Methods Subjects visiting primary care centers were invited to take part in the study. H. pylori status was assessed by 13C‐urea breath test (UBT). Data on subjects' demography, previous treatment exposure, and place of residence were collected in all federal districts of Russia in 2017 and in 2019 calendar years and processed centrally. Results The data of 19,875 subjects were available for analysis. The prevalence of H. pylori infection assessed by positive UBT in treatment‐naive subjects was highest in the Southern (54.9%) and the North Caucasian (45.1%) federal districts. A significant difference (p 
doi_str_mv 10.1111/hel.12924
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2702977763</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2702977763</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3304-5a97c6eba8d6c15df4b8f01c8dd467785032d44821d2e856d72125f36b6aba253</originalsourceid><addsrcrecordid>eNp1kctq3TAQhk1oIWnaRd9A0E27cKKLZcndhZD2BA4UclmbsTRuFHSsU0lOOLu8QKHQN8yTVO7pqpDZzIVv_hn4q-o9oyesxOkd-hPGO94cVEdMclFLofSrUlMt6kbo7rB6k9I9pVSKpjuqfq7QOxMGMBkj2e58iI64aUSTXZjINuIDeJwMliGBzTB7yCHuSMKc3fQ9LWNOmXp--l1St7RXt9fXl2efyc0dEgsZSBhJRPDPT78eQ_SWTLBogyeb2WdncFpO5-jAv61ej-ATvvuXj6vbLxc356t6_e3r5fnZujZC0KaW0CnT4gDatoZJOzaDHikz2tqmVUpLKrhtGs2Z5ahlaxVnXI6iHVoYgEtxXH3c625j-DFjyv3GJYPew4RhTj1XlHdKqVYU9MN_6H2YY_l-oZhktOtEW6hPe8rEkFLEsd9Gt4G46xntF2P6Ykz_15jCnu7ZR-dx9zLYry7W-40_b1KQuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2715109936</pqid></control><display><type>article</type><title>Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Bordin, Dmitry ; Morozov, Sergey ; Plavnik, Roman ; Bakulina, Natalia ; Voynovan, Irina ; Skibo, Irina ; Isakov, Vasily ; Bakulin, Igor ; Andreev, Dmitrii ; Maev, Igor</creator><creatorcontrib>Bordin, Dmitry ; Morozov, Sergey ; Plavnik, Roman ; Bakulina, Natalia ; Voynovan, Irina ; Skibo, Irina ; Isakov, Vasily ; Bakulin, Igor ; Andreev, Dmitrii ; Maev, Igor</creatorcontrib><description>Background The recent data on the prevalence of Helicobacter pylori (H. pylori) infection in Russia are limited. The aim of the study was to compare Helicobacter pylori infection prevalence in ambulatory settings in Russia in 2017 and 2019 years. Materials and Methods Subjects visiting primary care centers were invited to take part in the study. H. pylori status was assessed by 13C‐urea breath test (UBT). Data on subjects' demography, previous treatment exposure, and place of residence were collected in all federal districts of Russia in 2017 and in 2019 calendar years and processed centrally. Results The data of 19,875 subjects were available for analysis. The prevalence of H. pylori infection assessed by positive UBT in treatment‐naive subjects was highest in the Southern (54.9%) and the North Caucasian (45.1%) federal districts. A significant difference (p &lt; 0.05) in H. pylori prevalence between two testing periods was found only in a half of federal districts: the Central (46.2% in 2017 vs. 36.2% in 2019), the Northwestern (38.6% vs. 35.5% accordingly), the Volga (40.6% vs. 33.0%, accordingly), and the Ural (40.4% vs. 32.7%, accordingly). The lowest prevalence of H. pylori infection was revealed in the age group &lt;18 years old (20.2%), while the highest in the age group of 41–50 years old (43.9%). In 2017, the prevalence of H. pylori was significantly (p &lt; 0.05) higher than in 2019 in all age groups but younger than 18 and older than 70 y.o., where similar rates were found during both study periods. Conclusions The prevalence of H. pylori according to 13C‐UBT testing of primary care visitors in Russia is lower than expected (38.8%). The highest prevalence of H. pylori infection found in the Southern and the North Caucasian federal districts of Russia and in the age group of 41–50 years old. This study was registered at clinicaltrials.gov (NCT04892238).</description><identifier>ISSN: 1083-4389</identifier><identifier>EISSN: 1523-5378</identifier><identifier>DOI: 10.1111/hel.12924</identifier><language>eng</language><publisher>Oxford: Wiley Subscription Services, Inc</publisher><subject>Age ; Age groups ; Demography ; Helicobacter pylori ; Infections ; prevalence ; Primary care ; Russian Federation ; Urea ; urease breath test ; White people</subject><ispartof>Helicobacter (Cambridge, Mass.), 2022-10, Vol.27 (5), p.e12924-n/a</ispartof><rights>2022 John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2022 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3304-5a97c6eba8d6c15df4b8f01c8dd467785032d44821d2e856d72125f36b6aba253</citedby><cites>FETCH-LOGICAL-c3304-5a97c6eba8d6c15df4b8f01c8dd467785032d44821d2e856d72125f36b6aba253</cites><orcidid>0000-0002-5584-8514 ; 0000-0003-4075-4096 ; 0000-0001-6114-564X ; 0000-0001-5448-8812 ; 0000-0001-6816-3058 ; 0000-0002-6151-2021 ; 0000-0002-4007-7112 ; 0000-0003-2815-3992 ; 0000-0003-2418-6471 ; 0000-0002-4417-8076</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhel.12924$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhel.12924$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Bordin, Dmitry</creatorcontrib><creatorcontrib>Morozov, Sergey</creatorcontrib><creatorcontrib>Plavnik, Roman</creatorcontrib><creatorcontrib>Bakulina, Natalia</creatorcontrib><creatorcontrib>Voynovan, Irina</creatorcontrib><creatorcontrib>Skibo, Irina</creatorcontrib><creatorcontrib>Isakov, Vasily</creatorcontrib><creatorcontrib>Bakulin, Igor</creatorcontrib><creatorcontrib>Andreev, Dmitrii</creatorcontrib><creatorcontrib>Maev, Igor</creatorcontrib><title>Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial</title><title>Helicobacter (Cambridge, Mass.)</title><description>Background The recent data on the prevalence of Helicobacter pylori (H. pylori) infection in Russia are limited. The aim of the study was to compare Helicobacter pylori infection prevalence in ambulatory settings in Russia in 2017 and 2019 years. Materials and Methods Subjects visiting primary care centers were invited to take part in the study. H. pylori status was assessed by 13C‐urea breath test (UBT). Data on subjects' demography, previous treatment exposure, and place of residence were collected in all federal districts of Russia in 2017 and in 2019 calendar years and processed centrally. Results The data of 19,875 subjects were available for analysis. The prevalence of H. pylori infection assessed by positive UBT in treatment‐naive subjects was highest in the Southern (54.9%) and the North Caucasian (45.1%) federal districts. A significant difference (p &lt; 0.05) in H. pylori prevalence between two testing periods was found only in a half of federal districts: the Central (46.2% in 2017 vs. 36.2% in 2019), the Northwestern (38.6% vs. 35.5% accordingly), the Volga (40.6% vs. 33.0%, accordingly), and the Ural (40.4% vs. 32.7%, accordingly). The lowest prevalence of H. pylori infection was revealed in the age group &lt;18 years old (20.2%), while the highest in the age group of 41–50 years old (43.9%). In 2017, the prevalence of H. pylori was significantly (p &lt; 0.05) higher than in 2019 in all age groups but younger than 18 and older than 70 y.o., where similar rates were found during both study periods. Conclusions The prevalence of H. pylori according to 13C‐UBT testing of primary care visitors in Russia is lower than expected (38.8%). The highest prevalence of H. pylori infection found in the Southern and the North Caucasian federal districts of Russia and in the age group of 41–50 years old. This study was registered at clinicaltrials.gov (NCT04892238).</description><subject>Age</subject><subject>Age groups</subject><subject>Demography</subject><subject>Helicobacter pylori</subject><subject>Infections</subject><subject>prevalence</subject><subject>Primary care</subject><subject>Russian Federation</subject><subject>Urea</subject><subject>urease breath test</subject><subject>White people</subject><issn>1083-4389</issn><issn>1523-5378</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kctq3TAQhk1oIWnaRd9A0E27cKKLZcndhZD2BA4UclmbsTRuFHSsU0lOOLu8QKHQN8yTVO7pqpDZzIVv_hn4q-o9oyesxOkd-hPGO94cVEdMclFLofSrUlMt6kbo7rB6k9I9pVSKpjuqfq7QOxMGMBkj2e58iI64aUSTXZjINuIDeJwMliGBzTB7yCHuSMKc3fQ9LWNOmXp--l1St7RXt9fXl2efyc0dEgsZSBhJRPDPT78eQ_SWTLBogyeb2WdncFpO5-jAv61ej-ATvvuXj6vbLxc356t6_e3r5fnZujZC0KaW0CnT4gDatoZJOzaDHikz2tqmVUpLKrhtGs2Z5ahlaxVnXI6iHVoYgEtxXH3c625j-DFjyv3GJYPew4RhTj1XlHdKqVYU9MN_6H2YY_l-oZhktOtEW6hPe8rEkFLEsd9Gt4G46xntF2P6Ykz_15jCnu7ZR-dx9zLYry7W-40_b1KQuA</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Bordin, Dmitry</creator><creator>Morozov, Sergey</creator><creator>Plavnik, Roman</creator><creator>Bakulina, Natalia</creator><creator>Voynovan, Irina</creator><creator>Skibo, Irina</creator><creator>Isakov, Vasily</creator><creator>Bakulin, Igor</creator><creator>Andreev, Dmitrii</creator><creator>Maev, Igor</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5584-8514</orcidid><orcidid>https://orcid.org/0000-0003-4075-4096</orcidid><orcidid>https://orcid.org/0000-0001-6114-564X</orcidid><orcidid>https://orcid.org/0000-0001-5448-8812</orcidid><orcidid>https://orcid.org/0000-0001-6816-3058</orcidid><orcidid>https://orcid.org/0000-0002-6151-2021</orcidid><orcidid>https://orcid.org/0000-0002-4007-7112</orcidid><orcidid>https://orcid.org/0000-0003-2815-3992</orcidid><orcidid>https://orcid.org/0000-0003-2418-6471</orcidid><orcidid>https://orcid.org/0000-0002-4417-8076</orcidid></search><sort><creationdate>202210</creationdate><title>Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial</title><author>Bordin, Dmitry ; Morozov, Sergey ; Plavnik, Roman ; Bakulina, Natalia ; Voynovan, Irina ; Skibo, Irina ; Isakov, Vasily ; Bakulin, Igor ; Andreev, Dmitrii ; Maev, Igor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3304-5a97c6eba8d6c15df4b8f01c8dd467785032d44821d2e856d72125f36b6aba253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Age groups</topic><topic>Demography</topic><topic>Helicobacter pylori</topic><topic>Infections</topic><topic>prevalence</topic><topic>Primary care</topic><topic>Russian Federation</topic><topic>Urea</topic><topic>urease breath test</topic><topic>White people</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bordin, Dmitry</creatorcontrib><creatorcontrib>Morozov, Sergey</creatorcontrib><creatorcontrib>Plavnik, Roman</creatorcontrib><creatorcontrib>Bakulina, Natalia</creatorcontrib><creatorcontrib>Voynovan, Irina</creatorcontrib><creatorcontrib>Skibo, Irina</creatorcontrib><creatorcontrib>Isakov, Vasily</creatorcontrib><creatorcontrib>Bakulin, Igor</creatorcontrib><creatorcontrib>Andreev, Dmitrii</creatorcontrib><creatorcontrib>Maev, Igor</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Helicobacter (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bordin, Dmitry</au><au>Morozov, Sergey</au><au>Plavnik, Roman</au><au>Bakulina, Natalia</au><au>Voynovan, Irina</au><au>Skibo, Irina</au><au>Isakov, Vasily</au><au>Bakulin, Igor</au><au>Andreev, Dmitrii</au><au>Maev, Igor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial</atitle><jtitle>Helicobacter (Cambridge, Mass.)</jtitle><date>2022-10</date><risdate>2022</risdate><volume>27</volume><issue>5</issue><spage>e12924</spage><epage>n/a</epage><pages>e12924-n/a</pages><issn>1083-4389</issn><eissn>1523-5378</eissn><abstract>Background The recent data on the prevalence of Helicobacter pylori (H. pylori) infection in Russia are limited. The aim of the study was to compare Helicobacter pylori infection prevalence in ambulatory settings in Russia in 2017 and 2019 years. Materials and Methods Subjects visiting primary care centers were invited to take part in the study. H. pylori status was assessed by 13C‐urea breath test (UBT). Data on subjects' demography, previous treatment exposure, and place of residence were collected in all federal districts of Russia in 2017 and in 2019 calendar years and processed centrally. Results The data of 19,875 subjects were available for analysis. The prevalence of H. pylori infection assessed by positive UBT in treatment‐naive subjects was highest in the Southern (54.9%) and the North Caucasian (45.1%) federal districts. A significant difference (p &lt; 0.05) in H. pylori prevalence between two testing periods was found only in a half of federal districts: the Central (46.2% in 2017 vs. 36.2% in 2019), the Northwestern (38.6% vs. 35.5% accordingly), the Volga (40.6% vs. 33.0%, accordingly), and the Ural (40.4% vs. 32.7%, accordingly). The lowest prevalence of H. pylori infection was revealed in the age group &lt;18 years old (20.2%), while the highest in the age group of 41–50 years old (43.9%). In 2017, the prevalence of H. pylori was significantly (p &lt; 0.05) higher than in 2019 in all age groups but younger than 18 and older than 70 y.o., where similar rates were found during both study periods. Conclusions The prevalence of H. pylori according to 13C‐UBT testing of primary care visitors in Russia is lower than expected (38.8%). The highest prevalence of H. pylori infection found in the Southern and the North Caucasian federal districts of Russia and in the age group of 41–50 years old. This study was registered at clinicaltrials.gov (NCT04892238).</abstract><cop>Oxford</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1111/hel.12924</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5584-8514</orcidid><orcidid>https://orcid.org/0000-0003-4075-4096</orcidid><orcidid>https://orcid.org/0000-0001-6114-564X</orcidid><orcidid>https://orcid.org/0000-0001-5448-8812</orcidid><orcidid>https://orcid.org/0000-0001-6816-3058</orcidid><orcidid>https://orcid.org/0000-0002-6151-2021</orcidid><orcidid>https://orcid.org/0000-0002-4007-7112</orcidid><orcidid>https://orcid.org/0000-0003-2815-3992</orcidid><orcidid>https://orcid.org/0000-0003-2418-6471</orcidid><orcidid>https://orcid.org/0000-0002-4417-8076</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1083-4389
ispartof Helicobacter (Cambridge, Mass.), 2022-10, Vol.27 (5), p.e12924-n/a
issn 1083-4389
1523-5378
language eng
recordid cdi_proquest_miscellaneous_2702977763
source Wiley Online Library Journals Frontfile Complete
subjects Age
Age groups
Demography
Helicobacter pylori
Infections
prevalence
Primary care
Russian Federation
Urea
urease breath test
White people
title Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T04%3A59%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Helicobacter%20pylori%20infection%20prevalence%20in%20ambulatory%20settings%20in%202017%E2%80%932019%20in%20RUSSIA:%20The%20data%20of%20real%E2%80%90world%20national%20multicenter%20trial&rft.jtitle=Helicobacter%20(Cambridge,%20Mass.)&rft.au=Bordin,%20Dmitry&rft.date=2022-10&rft.volume=27&rft.issue=5&rft.spage=e12924&rft.epage=n/a&rft.pages=e12924-n/a&rft.issn=1083-4389&rft.eissn=1523-5378&rft_id=info:doi/10.1111/hel.12924&rft_dat=%3Cproquest_cross%3E2702977763%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2715109936&rft_id=info:pmid/&rfr_iscdi=true